Cresco Labs Inc. (CRLBF) stock
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Cresco Labs revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $655.85M, down 9.5% from the year before. The highest annual figure on record is $842.68M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $655.85M | -9.5% |
| FY2024 | Dec 31, 2024 | $724.34M | -6.0% |
| FY2023 | Dec 31, 2023 | $770.89M | -8.5% |
| FY2022 | Dec 31, 2022 | $842.68M | +2.6% |
| FY2021 | Dec 31, 2021 | $821.68M | +72.5% |
| FY2020 | Dec 31, 2020 | $476.25M | +270.5% |
| FY2019 | Dec 31, 2019 | $128.53M | – |
See a number that looks wrong?